Registry for outcomes of percutaneous tricuspid valve repair

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Pforzheim Tricuspid Valve Registry aims to evaluate the safety and effectiveness of the TriClip™ device in treating severe tricuspid regurgitation in critically ill patients. This observational study is conducted in a single-center, open-label format, focusing on patients who are symptomatic despite medical therapy. The registry will collect data on patient outcomes following the transcatheter edge-to-edge tricuspid valve repair procedure, providing insights into its real-world application and performance.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subjects (\>=18 years age) have severe tricuspid regurgitation and are symptomatic despite medical therapy.
* Subjects eligible to receive the TriClip™
* Subjects must provide written informed consent prior to study procedure.

Exclusion Criteria:

* Subjects participating in another clinical study that may impact the follow-up or results of this study.

Where it's running

• Helios Klinikum Pforzheim
  Pforzheim, Germany Recruiting

Study contacts

• Principal investigator: Ilka Ott, MD, PhD — Helios Klinikum Pforzheim
• Study coordinator: Ilka Ott, MD, PhD
• Email: Ilka.Ott@helios-pforzheim.de
• Phone: +4972319692955

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• 3D Echocardiography to See How CIEDs May Worsen Tricuspid Regurgitation

  This study tests whether different CIEDs (leadless pacemakers, LBBaP, and conventional pacemakers) differ in causing worsening tricuspid regurgitation, using 3D heart imaging.

  Recruiting Samsung Medical Center · Seoul, Seoul · NCT07793916

• CorVad Percutaneous Ventricular Assist System for Refractory Right Heart Failure

  This trial tests whether the CorVad percutaneous ventricular assist device can be safely used to help patients with stubborn right heart failure when medicines and support devices aren’t enough.

  Recruiting Shenzhen Core Medical Technology CO.,LTD. · Hefei, Anhui and 1 other locations · NCT07704424

• Compare leadless and left bundle branch pacemakers for heart and valve function

  This study tests whether leadless pacemakers or left bundle branch area pacing better preserve heart and tricuspid valve function in adults needing a pacemaker.

  Recruiting Guy's and St Thomas' NHS Foundation Trust · London · NCT07534917

• TriClip for treating tricuspid regurgitation in Japan

  This study will see if the TriClip device is safe and helps people in Japan with symptomatic severe tricuspid regurgitation when used in routine clinical care.

  Recruiting Abbott Medical Devices · Suita, Osaka · NCT07509658

• Impact of transcatheter tricuspid valve repair on kidneys, strength, and activity in older adults

  This study will try catheter-based tricuspid valve repair (TEER) in older adults with severe symptomatic tricuspid regurgitation to see if kidney function, fluid overload, and physical activity improve.

  Recruiting Robert Bosch Medical Center · Stuttgart · NCT07464106

• Right‑heart function and heart–lung interaction during ARDS with mechanical ventilation

  This project will follow adults with ARDS on mechanical ventilation to see how positive‑pressure breathing affects the right heart over time and how that relates to circulation.

  Recruiting Bicetre Hospital · Le Kremlin-Bicêtre · NCT07450846

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.